Recently, Juneyao Health announced information on its financial results for the first half of 2022. Although total revenue reached RMB 541 million yuan (USD $76 million), achieving a 13.42% growth, the net profit attributable to the company was only RMB 45.42 million yuan (USD $6.38 million), decreasing 63.51% year-on-year. Meanwhile, news came out claiming that Juneyao Health is laying out its liquor and automotive business.
As the first company listed with the label of “lactobacillus”, Juneyao Health did not gain high evaluation on its future development strategy from the investment market. With the cross-border business intentions, the company seems to lose the investment market confidence and its stock price has continued to fall for almost 4 weeks. (Source: sohu.com)
Visit HPA-China’s Information Hub, CLICK HERE